Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

First report of the rare RhCE-depleted D--phenotype in sixteen people of Iranian origin.

Shahverdi E, Moghaddam M, Abolghasemi H.

Vox Sang. 2019 Apr;114(3):256-261. doi: 10.1111/vox.12738. Epub 2019 Feb 19.

PMID:
30784072
2.

First Report of Known Rare Rhnull Phenotype Individuals in Iran.

Shahverdi E, Moghaddam M, Abolghasemi H.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):181-184.

3.

Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients.

Abolghasemi H, Panahi Y, Ahmadinejad M, Toogeh G, Karimi M, Eghbali A, Mirbehbahani NB, Dehdezi BK, Badiee Z, Hoorfar H, Eshghi P, Maghsoudi N, Sahebkar A, Gholami-Fesharaki M.

J Pharmacopuncture. 2018 Jun;21(2):76-81. doi: 10.3831/KPI.2018.21.009. Epub 2018 Jun 30.

4.

Molecular characterization of Glanzmann's thrombasthenia in Iran: identification of three novel mutations.

Kazemi A, Abolghasemi H, Kazemzadeh S, Vahidi R, Faranoush M, Farsinejad A, Ala F.

Blood Coagul Fibrinolysis. 2017 Dec;28(8):681-686. doi: 10.1097/MBC.0000000000000673.

PMID:
29084015
5.

Combined occurrence of Bernard-Soulier syndrome and prekallikrein deficiency.

Shahverdi E, Abolghasemi H, Ahmadinejad M.

Blood Res. 2017 Sep;52(3):229-231. doi: 10.5045/br.2017.52.3.229. Epub 2017 Sep 25. No abstract available.

6.

Distribution of blood groups in the Iranian general population.

Shahverdi E, Moghaddam M, Talebian A, Abolghasemi H.

Immunohematology. 2016 Dec;32(4):135-139. No abstract available.

PMID:
28257227
7.

Central Nervous System Toxoplasmosis in Relapsed Hodgkin's Lymphoma: A Case Report.

Abolghasemi H, Shahverdi E, Jafari R, Dolatimehr F, Khandani A.

Iran J Cancer Prev. 2016 Jun 11;9(4):e5810. eCollection 2016 Aug.

8.

Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study).

Toogeh G, Abolghasemi H, Eshghi P, Managhchi M, Shaverdi-Niasari M, Karimi K, Roostaei S, Emran N, Abdollahi A.

Iran J Pathol. 2016 Summer;11(3):204-209.

9.

Comparison of the Vitamin D Status of Children Younger and Older Than 2 Years in Tehran: Are Supplements Really Necessary?

Torkaman M, Abolghasemi H, Amirsalari S, Beiraghdar F, Afsharpaiman S, Kavehmanesh Z, Khosravi MH.

Int J Endocrinol Metab. 2016 Mar 13;14(2):e34676. doi: 10.5812/ijem.34676. eCollection 2016 Apr.

10.

Umbilical bleeding: a presenting feature for congenital afibrinogenemia.

Abolghasemi H, Shahverdi E.

Blood Coagul Fibrinolysis. 2015 Oct;26(7):834-5. doi: 10.1097/MBC.0000000000000368.

PMID:
26407137
11.

α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.

Najjari A, Asouri M, Gouhari LH, Niaki HA, Nejad AS, Eslami SM, Abolghasemi H, Ataee R, Ebrahimi AA, Moshaei MR, Ahmadi AA.

Asian Pac J Trop Biomed. 2014 May;4(Suppl 1):S177-85. doi: 10.12980/APJTB.4.2014C1161.

12.

Evaluation of the national prevention program in iran, 2007-2009: the accomplishments and challenges with reflections on the path ahead.

Hadipour Dehshal M, Tabrizi Namini M, Ahmadvand A, Manshadi M, Sadeghian Varnosfaderani F, Abolghasemi H.

Hemoglobin. 2014;38(3):179-87. doi: 10.3109/03630269.2014.893530. Epub 2014 Mar 26.

PMID:
24669933
13.

A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.

Faranoush M, Abolghasemi H, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M.

Clin Appl Thromb Hemost. 2015 Nov;21(8):724-8. doi: 10.1177/1076029614522545. Epub 2014 Mar 19.

PMID:
24651301
14.

The application of tissue-engineered preputial matrix and fibrin sealant for urethral reconstruction in rabbit model.

Kajbafzadeh AM, Sabetkish S, Tourchi A, Amirizadeh N, Afshar K, Abolghasemi H, Elmi A, Talab SS, Eshghi P, Mohseni MJ.

Int Urol Nephrol. 2014 Aug;46(8):1573-80. doi: 10.1007/s11255-014-0684-3. Epub 2014 Mar 12.

PMID:
24619583
15.

Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy.

Niknejad H, Khayat-Khoei M, Peirovi H, Abolghasemi H.

Cytotherapy. 2014 Jan;16(1):33-40. doi: 10.1016/j.jcyt.2013.07.005. Epub 2013 Oct 8.

PMID:
24113429
16.

Autologous fibrin sealant in tubeless percutaneous nephrolithotomy; a prospective study.

Ziaee SA, Sarhangnejad R, Abolghasemi H, Eshghi P, Radfar MH, Ahanian A, Kardoust Parizi M, Amirizadeh N, Nouralizadeh A.

Urol J. 2013 Sep 26;10(3):999-1003.

17.

Inhibition of HSP90 could be possible mechanism for anti-cancer property of amniotic membrane.

Niknejad H, Yazdanpanah G, Mirmasoumi M, Abolghasemi H, Peirovi H, Ahmadiani A.

Med Hypotheses. 2013 Nov;81(5):862-5. doi: 10.1016/j.mehy.2013.08.018. Epub 2013 Aug 30.

PMID:
24054818
18.

A change in standard of minimum hemoglobin for male blood donors in Iran.

Maghsudlu M, Nasizadeh S, Abolghasemi H, Amini Kafiabad S, Razjou F, Aghamohamadi A, Deyhim MR, Esmailifar G.

Transfus Apher Sci. 2013 Dec;49(3):463-7. doi: 10.1016/j.transci.2013.04.043. Epub 2013 Jun 12.

PMID:
23768688
19.

Serum-free cryopreservation of human amniotic epithelial cells before and after isolation from their natural scaffold.

Niknejad H, Deihim T, Peirovi H, Abolghasemi H.

Cryobiology. 2013 Aug;67(1):56-63. doi: 10.1016/j.cryobiol.2013.05.001. Epub 2013 May 16.

PMID:
23685252
20.

Secular trends in the national and provincial births of new thalassemia cases in Iran from 2001 to 2006.

Dehshal MH, Ahmadvand A, Darestani SY, Manshadi M, Abolghasemi H.

Hemoglobin. 2013;37(2):124-37. doi: 10.3109/03630269.2013.772062.

PMID:
23470148
21.

Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study.

Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, Abolghasemi H.

Int J Prev Med. 2012 Nov;3(11):770-5.

22.

The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells.

Nikougoftar Zarif M, Soleimani M, Abolghasemi H, Amirizade N, Abroun S, Kaviani S.

Cell J. 2011 Fall;13(3):173-8. Epub 2011 Sep 23.

23.

Effects of CXCR1 and CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133(+) cells into megakaryocyte progenitor cells.

Adeli EK, Abolghasemi H, Ebtekar M, Pourpak Z, Kheirandish M.

Cytokine. 2011 Aug;55(2):181-7. doi: 10.1016/j.cyto.2011.04.015. Epub 2011 May 8.

PMID:
21555225
24.

Full genome characterization of hepatitis B virus strains from blood donors in Iran.

Garmiri P, Rezvan H, Abolghasemi H, Allain JP.

J Med Virol. 2011 Jun;83(6):948-52. doi: 10.1002/jmv.21772.

PMID:
21503905
25.

Detection of malaria infection in blood transfusion: a comparative study among real-time PCR, rapid diagnostic test and microscopy: sensitivity of Malaria detection methods in blood transfusion.

Hassanpour G, Mohebali M, Raeisi A, Abolghasemi H, Zeraati H, Alipour M, Azizi E, Keshavarz H.

Parasitol Res. 2011 Jun;108(6):1519-23. doi: 10.1007/s00436-010-2207-1. Epub 2011 Jan 8.

PMID:
21221645
26.

Platelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cells.

Aghideh AN, Kheirandish M, Abolghasemi H, Gharehbaghian A.

Growth Factors. 2010 Dec;28(6):409-16. doi: 10.3109/08977194.2010.504722. Epub 2010 Sep 21.

PMID:
20854188
27.

Single-donor fibrin sealant for repair of urethrocutaneous fistulae following multiple hypospadias and epispadias repairs.

Kajbafzadeh AM, Abolghasemi H, Eshghi P, Alizadeh F, Elmi A, Shafaattalab S, Dianat S, Amirizadeh N, Mohseni MJ.

J Pediatr Urol. 2011 Aug;7(4):422-7. doi: 10.1016/j.jpurol.2010.06.004. Epub 2010 Jul 15.

PMID:
20634140
28.

Childhood physical abnormalities following paternal exposure to sulfur mustard gas in Iran: a case-control study.

Abolghasemi H, Radfar MH, Rambod M, Salehi P, Ghofrani H, Soroush MR, Falahaty F, Tavakolifar Y, Sadaghianifar A, Khademolhosseini SM, Kavehmanesh Z, Joffres M, Burkle FM Jr, Mills EJ.

Confl Health. 2010 Jul 14;4:13. doi: 10.1186/1752-1505-4-13.

29.

Estimating blood transfusion requirements in preparation for a major earthquake: the Tehran, Iran study.

Tabatabaie M, Ardalan A, Abolghasemi H, Holakouie Naieni K, Pourmalek F, Ahmadi B, Shokouhi M.

Prehosp Disaster Med. 2010 May-Jun;25(3):246-52.

PMID:
20586006
30.

Blood donor incentives: A step forward or backward.

Abolghasemi H, Hosseini-Divkalayi NS, Seighali F.

Asian J Transfus Sci. 2010 Jan;4(1):9-13. doi: 10.4103/0973-6247.59385.

31.

Seroprevalence of hepatitis C virus: the first population-based study from Iran.

Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S.

Int J Infect Dis. 2010 Sep;14 Suppl 3:e113-6. doi: 10.1016/j.ijid.2009.11.032. Epub 2010 Apr 2.

32.

Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study.

Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R.

Arch Iran Med. 2010 Mar;13(2):99-104.

33.

Improving availability and affordability of plasma-derived medicines.

Cheraghali AM, Abolghasemi H.

Biologicals. 2010 Jan;38(1):81-6. doi: 10.1016/j.biologicals.2009.10.004. Review.

PMID:
20137973
34.

Blood donation and donor recruitment in Iran from 1998 through 2007: ten years' experience.

Maghsudlu M, Nasizadeh S, Abolghasemi H, Ahmadyar S.

Transfusion. 2009 Nov;49(11):2346-51. doi: 10.1111/j.1537-2995.2009.02309.x. Epub 2009 Jul 14.

PMID:
19624488
35.

Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.

Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A.

Transfusion. 2009 Oct;49(10):2214-20. doi: 10.1111/j.1537-2995.2009.02245.x. Epub 2009 Jun 10.

PMID:
19527477
36.

The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.

Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R.

Arch Iran Med. 2009 May;12(3):225-31.

37.

Revisiting blood transfusion preparedness: experience from the Bam earthquake response.

Abolghasemi H, Radfar MH, Tabatabaee M, Hosseini-Divkolayee NS, Burkle FM Jr.

Prehosp Disaster Med. 2008 Sep-Oct;23(5):391-4.

PMID:
19189607
38.

Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors.

Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, Jafari AM.

Pak J Biol Sci. 2007 Dec 15;10(24):4461-6.

PMID:
19093512
39.

Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.

Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, Abolghasemi H, Amini S, Maghsoudlu M, Deyhim MR, Rezvan H, Pourshams A.

World J Gastroenterol. 2008 May 14;14(18):2867-71.

40.

Thalassemia in Iran: epidemiology, prevention, and management.

Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, Ehsani MA, Najmabadi H, Akbari MT, Afrasiabi A, Akhavan-Niaki H, Hoorfar H.

J Pediatr Hematol Oncol. 2007 Apr;29(4):233-8.

PMID:
17414565
41.

Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.

Khedmat H, Fallahian F, Abolghasemi H, Hajibeigi B, Attarchi Z, Alaeddini F, Holisaz MT, Pourali M, Sharifi S, Zarei N.

World J Gastroenterol. 2007 Feb 14;13(6):889-94.

42.

Pediatric trauma at tertiary-level hospitals in the aftermath of the Bam, Iran Earthquake.

Sabzehchian M, Abolghasemi H, Radfar MH, Jonaidi-Jafari N, Ghasemzadeh H, Burkle FM Jr.

Prehosp Disaster Med. 2006 Sep-Oct;21(5):336-9.

PMID:
17297904
43.

International medical response to a natural disaster: lessons learned from the Bam earthquake experience.

Abolghasemi H, Radfar MH, Khatami M, Nia MS, Amid A, Briggs SM.

Prehosp Disaster Med. 2006 May-Jun;21(3):141-7.

PMID:
16892878
44.

Iranian military forces in the Bam earthquake.

Abolghasemi H, Poorheidari G, Mehrabi A, Foroutan G.

Mil Med. 2005 Oct;170(10):859-61.

PMID:
16435759
45.

The IVS-II-1 (G-->a) beta0-thalassemia mutation in cis with HbA2-Troodos [delta116(G18)Arg-->Cys (CGC-->TGC)] causes a complex prenatal diagnosis in an Iranian family.

Eram SM, Azimifar B, Abolghasemi H, Foulady P, Lotfi V, Masrouri M, Hosseini M, Abdolhosseini A, Zeinali S.

Hemoglobin. 2005;29(4):289-92.

PMID:
16370491
46.

Clinical quiz.

Abolghasemi H, Kavehmanesh Z, Matinzadeh ZK, Amid A, Ahmadi M.

J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):229, 243. No abstract available.

PMID:
15711419
47.

Maternal Ramadan fasting and neonatal health.

Kavehmanesh Z, Abolghasemi H.

J Perinatol. 2004 Dec;24(12):748-50.

PMID:
15343350
48.

Supplemental Content

Loading ...
Support Center